451 related articles for article (PubMed ID: 20547125)
1. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice.
Lee JK; Geoffroy CG; Chan AF; Tolentino KE; Crawford MJ; Leal MA; Kang B; Zheng B
Neuron; 2010 Jun; 66(5):663-70. PubMed ID: 20547125
[TBL] [Abstract][Full Text] [Related]
2. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
Cafferty WB; Duffy P; Huebner E; Strittmatter SM
J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
[TBL] [Abstract][Full Text] [Related]
3. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory proteins against axon regeneration in the central nervous system].
Hu JG; Lu PH; Xu XM
Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
[TBL] [Abstract][Full Text] [Related]
5. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.
Lee JK; Chow R; Xie F; Chow SY; Tolentino KE; Zheng B
J Neurosci; 2010 Aug; 30(32):10899-904. PubMed ID: 20702718
[TBL] [Abstract][Full Text] [Related]
6. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
7. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
[TBL] [Abstract][Full Text] [Related]
8. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
Hunt D; Coffin RS; Anderson PN
J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
[TBL] [Abstract][Full Text] [Related]
9. Axon regeneration in young adult mice lacking Nogo-A/B.
Kim JE; Li S; GrandPré T; Qiu D; Strittmatter SM
Neuron; 2003 Apr; 38(2):187-99. PubMed ID: 12718854
[TBL] [Abstract][Full Text] [Related]
10. Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury.
Ji B; Case LC; Liu K; Shao Z; Lee X; Yang Z; Wang J; Tian T; Shulga-Morskaya S; Scott M; He Z; Relton JK; Mi S
Mol Cell Neurosci; 2008 Oct; 39(2):258-67. PubMed ID: 18692574
[TBL] [Abstract][Full Text] [Related]
11. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
12. Lack of enhanced spinal regeneration in Nogo-deficient mice.
Zheng B; Ho C; Li S; Keirstead H; Steward O; Tessier-Lavigne M
Neuron; 2003 Apr; 38(2):213-24. PubMed ID: 12718856
[TBL] [Abstract][Full Text] [Related]
13. Regulating axon growth within the postnatal central nervous system.
Hu F; Strittmatter SM
Semin Perinatol; 2004 Dec; 28(6):371-8. PubMed ID: 15693393
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
[TBL] [Abstract][Full Text] [Related]
15. Myelin-associated inhibitors of axon regeneration.
Grados-Munro EM; Fournier AE
J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
[TBL] [Abstract][Full Text] [Related]
16. Nogo on the go.
McKerracher L; Winton MJ
Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic DNA vaccination as a repair strategy following spinal cord injury.
Kou SB; Xu G; Jiang XD; Xu RX; Tang YP; Xu G; Cai YQ; Du MX; Xiao ZC
Cell Mol Neurobiol; 2010 Mar; 30(2):275-82. PubMed ID: 19757023
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of corticospinal tract regeneration in Nogo-deficient mice.
Lee JK; Chan AF; Luu SM; Zhu Y; Ho C; Tessier-Lavigne M; Zheng B
J Neurosci; 2009 Jul; 29(27):8649-54. PubMed ID: 19587271
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanism and regulation of axon growth inhibition].
Yamashita T
Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
[TBL] [Abstract][Full Text] [Related]
20. PirB is a functional receptor for myelin inhibitors of axonal regeneration.
Atwal JK; Pinkston-Gosse J; Syken J; Stawicki S; Wu Y; Shatz C; Tessier-Lavigne M
Science; 2008 Nov; 322(5903):967-70. PubMed ID: 18988857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
